DRUG BRIGHT MINDS BIOSCIENCES INC.
Price Chart
Executive Summary
Bright Minds Biosciences Inc. filed a Form 6-K with the SEC on June 2, 2026, providing notice of its Annual General Meeting scheduled for March 31, 2026, with a record date of February 10, 2026. The filing is a routine procedural notification with no financial data, business updates, or material events disclosed.
Actionable Insight
This filing is purely administrative with no trading implications. Monitor future filings for clinical trial updates, financial results, or corporate developments that could affect the stock.
Key Facts
- Annual General Meeting scheduled for March 31, 2026.
- Record date for notice and voting is February 10, 2026.
- Meeting location is Vancouver, BC.
- No financial results, guidance, or business developments were disclosed in the filing.
- The filing was signed by CFO Ryan Cheung on June 2, 2026.
Financial Impact
No financial impact — filing contains only administrative meeting details.
Risk Factors
- No material risks identified from this filing.
Market Snapshot
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001062993-26-002975 |
| Document: form6k.htm | 0001062993-26-002975 |
| Document: 0001062993-26-002975-index-headers.html | 0001062993-26-002975 |
| Document: 0001062993-26-002975-index.html | 0001062993-26-002975 |
| Document: 0001062993-26-002975.txt | 0001062993-26-002975 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 3, 2026
9d ago
|
6-K
| $74.42 $74.50 | ▲ +0.11% | ▼ −0.29% | $60.95 (−18.10%) |
|
Jun 2, 2026
10d ago
|
6-K
| $76.78 $74.42 | ▼ −3.07% | ▼ −2.38% | $60.95 (−20.62%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access